Research ArticleArticle
Identification and Pharmacological Characterization of Multiple Allosteric Binding Sites on the Free Fatty Acid 1 Receptor
Daniel C.-H. Lin, Qi Guo, Jian Luo, Jane Zhang, Kathy Nguyen, Michael Chen, Thanh Tran, Paul J. Dransfield, Sean P. Brown, Jonathan Houze, Marc Vimolratana, Xian Yun Jiao, Yingcai Wang, Nigel J. M. Birdsall and Gayathri Swaminath
Molecular Pharmacology November 2012, 82 (5) 843-859; DOI: https://doi.org/10.1124/mol.112.079640
Daniel C.-H. Lin
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Qi Guo
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Jian Luo
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Jane Zhang
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Kathy Nguyen
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Michael Chen
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Thanh Tran
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Paul J. Dransfield
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Sean P. Brown
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Jonathan Houze
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Marc Vimolratana
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Xian Yun Jiao
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Yingcai Wang
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Nigel J. M. Birdsall
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Gayathri Swaminath
Amgen Inc., South San Francisco, California (D.C.-H.L., Q.G., J.L., J.Z., K.N., M.C., T.T., P.J.D., S.P.B., J.H., M.V., X.Y.J., Y.W., G.S.); and Division of Physical Biochemistry, MRC National Institute for Medical Research, London, United Kingdom (N.J.M.B.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Allosteric Binding Sites on the FFA1 Receptor
Daniel C.-H. Lin, Qi Guo, Jian Luo, Jane Zhang, Kathy Nguyen, Michael Chen, Thanh Tran, Paul J. Dransfield, Sean P. Brown, Jonathan Houze, Marc Vimolratana, Xian Yun Jiao, Yingcai Wang, Nigel J. M. Birdsall and Gayathri Swaminath
Molecular Pharmacology November 1, 2012, 82 (5) 843-859; DOI: https://doi.org/10.1124/mol.112.079640
Research ArticleArticle
Allosteric Binding Sites on the FFA1 Receptor
Daniel C.-H. Lin, Qi Guo, Jian Luo, Jane Zhang, Kathy Nguyen, Michael Chen, Thanh Tran, Paul J. Dransfield, Sean P. Brown, Jonathan Houze, Marc Vimolratana, Xian Yun Jiao, Yingcai Wang, Nigel J. M. Birdsall and Gayathri Swaminath
Molecular Pharmacology November 1, 2012, 82 (5) 843-859; DOI: https://doi.org/10.1124/mol.112.079640
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement